Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura

Intern Med. 2002 Dec;41(12):1199-203. doi: 10.2169/internalmedicine.41.1199.

Abstract

Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose gamma-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antigens, Nuclear / immunology*
  • Antithyroid Agents / therapeutic use
  • Autoantibodies / blood*
  • DNA Helicases*
  • DNA-Binding Proteins / immunology*
  • Dermatomyositis / complications*
  • Dermatomyositis / drug therapy
  • Dermatomyositis / immunology
  • Female
  • Graves Disease / complications*
  • Graves Disease / drug therapy
  • Graves Disease / immunology
  • Humans
  • Ku Autoantigen
  • Methimazole / therapeutic use
  • Platelet Transfusion
  • Propylthiouracil / therapeutic use
  • Purpura, Thrombocytopenic, Idiopathic / complications*
  • Purpura, Thrombocytopenic, Idiopathic / immunology
  • Purpura, Thrombocytopenic, Idiopathic / therapy
  • Scleroderma, Systemic / complications*
  • Scleroderma, Systemic / drug therapy
  • Scleroderma, Systemic / immunology
  • Steroids

Substances

  • Anti-Inflammatory Agents
  • Antigens, Nuclear
  • Antithyroid Agents
  • Autoantibodies
  • DNA-Binding Proteins
  • Steroids
  • Methimazole
  • Propylthiouracil
  • DNA Helicases
  • XRCC5 protein, human
  • Xrcc6 protein, human
  • Ku Autoantigen